Summary
Les Laboratoires Servier SAS (Servier) is a pharmaceutical company. It carries out research and development, manufacture and marketing of drugs for the treatment of various diseases including cardiovascular diseases, diabetes and cancer. The company's portfolio of marketed products covers various categories including cardiovascular disease, rheumatology, ENT, venous disease, neurosciences, asthenia, cancer and endocrine disorders. The company operates International Centers for Therapeutic Research (ICTR) in 19 cities including London, Madrid, Melbourne, Montreal, Moscow and Munich. The company has presence in around 140 countries worldwide.
Les Laboratoires Servier SAS Key Recent Developments
Jan 07, 2013: Vernalis And Servier Achieve Research Milestone In Third Oncology Collaboration
Sep 28, 2012: Florey Institute Of Neuroscience And Mental Health Collaborates With Servier To Conduct Research On New Target For Alzheimer’s Disease
Sep 20, 2012: Vernalis And Servier Achieve Research Milestone In First Oncology Collaboration
Jul 24, 2012: Galapagos Delivers Candidate Drug In Osteoarthritis Alliance With Servier
Jun 29, 2012: Mark Edwards Awarded IOF-SERVIER Research Grant
GlobalData’s Les Laboratoires Servier SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
Reasons to Buy
Les Laboratoires Servier SAS (Servier) is a pharmaceutical company. It carries out research and development, manufacture and marketing of drugs for the treatment of various diseases including cardiovascular diseases, diabetes and cancer. The company's portfolio of marketed products covers various categories including cardiovascular disease, rheumatology, ENT, venous disease, neurosciences, asthenia, cancer and endocrine disorders. The company operates International Centers for Therapeutic Research (ICTR) in 19 cities including London, Madrid, Melbourne, Montreal, Moscow and Munich. The company has presence in around 140 countries worldwide.
Les Laboratoires Servier SAS Key Recent Developments
Jan 07, 2013: Vernalis And Servier Achieve Research Milestone In Third Oncology Collaboration
Sep 28, 2012: Florey Institute Of Neuroscience And Mental Health Collaborates With Servier To Conduct Research On New Target For Alzheimer’s Disease
Sep 20, 2012: Vernalis And Servier Achieve Research Milestone In First Oncology Collaboration
Jul 24, 2012: Galapagos Delivers Candidate Drug In Osteoarthritis Alliance With Servier
Jun 29, 2012: Mark Edwards Awarded IOF-SERVIER Research Grant
GlobalData’s Les Laboratoires Servier SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
SECTION 1 - ABOUT THE COMPANY
Les Laboratoires Servier SAS - Key Facts
Les Laboratoires Servier SAS - Key Employees
Les Laboratoires Servier SAS - Major Products and Services
Les Laboratoires Servier SAS - Pharmaceutical Pipeline Products Data
Les Laboratoires Servier SAS, Pipeline Products by Therapy Area
Les Laboratoires Servier SAS, Pipeline Products by Development Phase
Les Laboratoires Servier SAS - History
Les Laboratoires Servier SAS - Company Statement
Les Laboratoires Servier SAS - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
SECTION 2 – COMPANY ANALYSIS
Les Laboratoires Servier SAS - Business Description
Les Laboratoires Servier SAS - SWOT Analysis
SWOT Analysis - Overview
Les Laboratoires Servier SAS - Strengths
Strength - Broad Product Portfolio
Strength - Strong In-house Research Capabilities
Strength - Widespread Geographic Presence
Les Laboratoires Servier SAS - Weaknesses
Weakness - Antitrust Investigation
Weakness - Litigations Related to Mediator
Les Laboratoires Servier SAS - Opportunities
Opportunity - Agreements and Collaborations
Opportunity - Growing Aged Population in France
Opportunity - Emerging Markets
Les Laboratoires Servier SAS - Threats
Threat - Increasing Competitive Pressures
Threat - Uncertain R&D Outcomes
Threat - Stringent Government Regulations
Les Laboratoires Servier SAS - Key Competitors
SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Les Laboratoires Servier SAS, Recent Deals Summary
SECTION 4 – COMPANY’S RECENT DEVELOPMENTS
Les Laboratoires Servier SAS, Recent Developments
Jan 07, 2013: Vernalis And Servier Achieve Research Milestone In Third Oncology Collaboration
Sep 28, 2012: Florey Institute Of Neuroscience And Mental Health Collaborates With Servier To Conduct Research On New Target For Alzheimer’s Disease
Sep 20, 2012: Vernalis And Servier Achieve Research Milestone In First Oncology Collaboration
Sep 20, 2012: Vernalis And Servier Achieve Research Milestone In First Oncology Collaboration
Jul 24, 2012: Galapagos Delivers Candidate Drug In Osteoarthritis Alliance With Servier
Jul 24, 2012: Galapagos Delivers Candidate Drug In Osteoarthritis Alliance With Servier
Jun 29, 2012: Mark Edwards Awarded IOF-SERVIER Research Grant
Jun 29, 2012: Servier Institutes €30,000 Research Grant In Hypertension
Jun 04, 2012: Servier And Genepep Announce Renewal And Extension Of Collaborative Contract For Development Of Chemical Protein Synthesis
Apr 25, 2012: Vernalis And Servier Achieve Research Milestone In Drug Discovery Collaboration
SECTION 5 – APPENDIX
Methodology
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Les Laboratoires Servier SAS, Key Facts
Les Laboratoires Servier SAS, Key Employees
Les Laboratoires Servier SAS, Major Products and Services
Les Laboratoires Servier SAS, Number of Pipeline Products by Therapy Area
Les Laboratoires Servier SAS, Number of Pipeline Products by Development Stage
Les Laboratoires Servier SAS, Pipeline Products By Therapy Area and Development Phase
Les Laboratoires Servier SAS, History
Les Laboratoires Servier SAS, Other Locations
Les Laboratoires Servier SAS, Subsidiaries
Les Laboratoires Servier SAS, Joint Venture
Les Laboratoires Servier SAS, Key Competitors
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Les Laboratoires Servier SAS, Recent Deals Summary
LIST OF FIGURES
Les Laboratoires Servier SAS, Pipeline Products by Therapy Area
Les Laboratoires Servier SAS, Pipeline Products by Development Phase
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013
Les Laboratoires Servier SAS - Key Facts
Les Laboratoires Servier SAS - Key Employees
Les Laboratoires Servier SAS - Major Products and Services
Les Laboratoires Servier SAS - Pharmaceutical Pipeline Products Data
Les Laboratoires Servier SAS, Pipeline Products by Therapy Area
Les Laboratoires Servier SAS, Pipeline Products by Development Phase
Les Laboratoires Servier SAS - History
Les Laboratoires Servier SAS - Company Statement
Les Laboratoires Servier SAS - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
SECTION 2 – COMPANY ANALYSIS
Les Laboratoires Servier SAS - Business Description
Les Laboratoires Servier SAS - SWOT Analysis
SWOT Analysis - Overview
Les Laboratoires Servier SAS - Strengths
Strength - Broad Product Portfolio
Strength - Strong In-house Research Capabilities
Strength - Widespread Geographic Presence
Les Laboratoires Servier SAS - Weaknesses
Weakness - Antitrust Investigation
Weakness - Litigations Related to Mediator
Les Laboratoires Servier SAS - Opportunities
Opportunity - Agreements and Collaborations
Opportunity - Growing Aged Population in France
Opportunity - Emerging Markets
Les Laboratoires Servier SAS - Threats
Threat - Increasing Competitive Pressures
Threat - Uncertain R&D Outcomes
Threat - Stringent Government Regulations
Les Laboratoires Servier SAS - Key Competitors
SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Les Laboratoires Servier SAS, Recent Deals Summary
SECTION 4 – COMPANY’S RECENT DEVELOPMENTS
Les Laboratoires Servier SAS, Recent Developments
Jan 07, 2013: Vernalis And Servier Achieve Research Milestone In Third Oncology Collaboration
Sep 28, 2012: Florey Institute Of Neuroscience And Mental Health Collaborates With Servier To Conduct Research On New Target For Alzheimer’s Disease
Sep 20, 2012: Vernalis And Servier Achieve Research Milestone In First Oncology Collaboration
Sep 20, 2012: Vernalis And Servier Achieve Research Milestone In First Oncology Collaboration
Jul 24, 2012: Galapagos Delivers Candidate Drug In Osteoarthritis Alliance With Servier
Jul 24, 2012: Galapagos Delivers Candidate Drug In Osteoarthritis Alliance With Servier
Jun 29, 2012: Mark Edwards Awarded IOF-SERVIER Research Grant
Jun 29, 2012: Servier Institutes €30,000 Research Grant In Hypertension
Jun 04, 2012: Servier And Genepep Announce Renewal And Extension Of Collaborative Contract For Development Of Chemical Protein Synthesis
Apr 25, 2012: Vernalis And Servier Achieve Research Milestone In Drug Discovery Collaboration
SECTION 5 – APPENDIX
Methodology
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Les Laboratoires Servier SAS, Key Facts
Les Laboratoires Servier SAS, Key Employees
Les Laboratoires Servier SAS, Major Products and Services
Les Laboratoires Servier SAS, Number of Pipeline Products by Therapy Area
Les Laboratoires Servier SAS, Number of Pipeline Products by Development Stage
Les Laboratoires Servier SAS, Pipeline Products By Therapy Area and Development Phase
Les Laboratoires Servier SAS, History
Les Laboratoires Servier SAS, Other Locations
Les Laboratoires Servier SAS, Subsidiaries
Les Laboratoires Servier SAS, Joint Venture
Les Laboratoires Servier SAS, Key Competitors
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Les Laboratoires Servier SAS, Recent Deals Summary
LIST OF FIGURES
Les Laboratoires Servier SAS, Pipeline Products by Therapy Area
Les Laboratoires Servier SAS, Pipeline Products by Development Phase
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013
